Literature DB >> 7781352

Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD.

M J Mador1, A Rodis, U J Magalang.   

Abstract

The purpose of this study was to evaluate the moderate term (5 weeks) reproducibility of Borg scale ratings of the effort to breathe (Borge) and the degree of discomfort evoked by breathing (Borgd) in patients with COPD during exercise. Six subjects with moderately severe COPD (FEV1, 1.42 +/- 0.50 L) underwent progressive incremental exercise (15 W/min) on a cycle ergometer to a symptom-limited maximum every week for 6 weeks (first week used as practice session). Minute ventilation (VE), oxygen consumption (VO2), and Borg ratings were obtained every minute during exercise. Borge and Borgd were highly correlated in each subject (r = 0.99 +/- 0.01). Borg scores were not significantly different across study days during both maximal and submaximal exercise. The within-subject coefficient of variation (CV) for Borge during maximal exercise was 13.9 +/- 9.0% (range, 6 to 31%) which was not significantly different from that observed for the physiological indices: 8.2 +/- 4.1% (range, 4 to 15%) for VE and 5.2 +/- 3.4% (range, 1 to 10%) for VO2. In contrast, at 66% of the maximum workload, the within-subject CV for Borge was 25.0 +/- 13.6% (range, 12 to 50%) which was significantly greater than that observed for the physiologic indices: 5.8 +/- 2.0% (range, 3 to 9%) for VE and 4.6 +/- 1.1% (range, 3 to 6%) for VO2. In every subject, Borge was linearly correlated with VE, VO2, and workload. However, within an individual subject, the slope of these relationships varied between trials; within-subject CV for the slope of the Borge/VE relationship was 20.2 +/- 8.0% (range, 12 to 32%). In conclusion, during incremental exercise Borg ratings of dyspnea are not as reproducible as physiologic indices in patients with COPD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781352     DOI: 10.1378/chest.107.6.1590

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  35 in total

1.  Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.

Authors:  Ali Iranmanesh; Dudley F Rochester; Jing Liu; Johannes D Veldhuis
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Sleep in patients with large pleural effusion: impact of thoracentesis.

Authors:  Bianca Fernandes Marcondes; Francisco Vargas; Fabio Henrique Paschoal; Ana Maria Cartaxo; Lisete R Teixeira; Eduardo Henrique Genofre; Roberto Onishi; Robert Skomro; Geraldo Lorenzi-Filho
Journal:  Sleep Breath       Date:  2011-05-15       Impact factor: 2.816

3.  Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment.

Authors:  Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey
Journal:  Eur J Appl Physiol       Date:  2020-04-06       Impact factor: 3.078

4.  Influence of Pulmonary Rehabilitation on Lung Function Changes After the Lung Resection for Primary Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Natasa Mujovic; Nebojsa Mujovic; Dragan Subotic; Maja Ercegovac; Andjela Milovanovic; Ljubica Nikcevic; Vladimir Zugic; Dejan Nikolic
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

Review 5.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

6.  Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis.

Authors:  Esam H Alhamad; Shaffi Ahmad Shaik; Majdy M Idrees; Mohammed O Alanezi; Arthur C Isnani
Journal:  BMC Pulm Med       Date:  2010-08-09       Impact factor: 3.317

7.  Dyspnea and pain frequently co-occur among Medicare managed care recipients.

Authors:  Nathan Clark; Vincent S Fan; Christopher G Slatore; Emily Locke; Heather E Whitson; Linda Nici; Stephen M Thielke
Journal:  Ann Am Thorac Soc       Date:  2014-07

8.  Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention.

Authors:  S G Cloosterman; I D Hofland; C P van Schayck; H T Folgering
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

9.  Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure.

Authors:  Sarah Damanti; Giuseppe Alvise Ramirez; Enrica Paola Bozzolo; Patrizia Rovere-Querini; Rebecca De Lorenzo; Cristiano Magnaghi; Raffaella Scotti; Giuseppe Di Lucca; Alessandro Marinosci; Silvia Strada; Gaetano Di Terlizzi; Giordano Vitali; Sabina Martinenghi; Nicola Compagnone; Giovanni Landoni; Moreno Tresoldi
Journal:  Intern Med J       Date:  2021-11       Impact factor: 2.611

10.  The tolerance of physiotherapy treatment in patients with COVID-19 and undergoing surgery for fragility hip fracture: An observational study.

Authors:  Mattia Morri; Antonio Culcasi; Riccardo Ruisi; Debora Raffa; Tania Sabattini; Roberta Bardelli; Antonella Magli Orlandi
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.